lysophosphatidic acid has been researched along with Epithelial Ovarian Cancer in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 11 (78.57) | 24.3611 |
| 2020's | 3 (21.43) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, B; Huang, X; Li, S; Liu, M; Liu, Z; Zeng, W | 1 |
| Conejo-Garcia, JR; Curiel, TJ | 1 |
| Bos, B; Campbell, L; Kim, O; Klymenko, Y; Liu, Y; Loughran, E; Stack, MS; Yang, J | 1 |
| Bailey, KA; Feist, PE; Hummon, AB; Klymenko, Y; Schultz, ZD; Stack, MS | 1 |
| Heo, SC; Jeong, GO; Kim, JH; Kim, KH; Kwon, YW; Seo, EJ; Shin, SH; Suh, DS; Yoon, MS | 1 |
| Cecerska, E; Dolegowska, B; Jesionowska, A | 1 |
| Burkhalter, RJ; Liu, Y; Stack, MS; Westfall, SD | 1 |
| Cai, Q; Fan, Q; Xu, Y | 1 |
| Carolan, A; Ellerbroek, SM; Farley, J; Gardner, N; Henningsen, M; Heying, E; Huegel, K; Kobliska, A; Kotecki, A; Lizalek, J; Lundt, A; Marsh, S; McKenna, T; Miller, G | 1 |
| Aoki, J; Choi, EJ; Choi, KU; Jang, IH; Kim, DK; Kim, JH; Kim, KH; Kim, KP; Kwon, YW; Lee, JH; Lee, JW; Lee, SI; Matsumoto, H; Mok, HJ; Seo, EJ; Suh, DS | 1 |
| Choi, KU; Choi, YJ; Heo, SC; Jeon, ES; Kim, JH; Lee, IH; Shin, SH; Suh, DS; Yoon, MS; Yun, JS | 1 |
| Fisher, J; Fishman, DA; Wang, FQ | 1 |
| Dutta, S; Fishman, DA; Mukherjee, TJ; Wang, FQ; Wu, HS | 1 |
| Antalis, C; Cai, Q; Del Priore, G; Hamed, AH; Schilder, JM; Stehman, FB; Xu, Y; Yan, L; Zhao, Z | 1 |
2 review(s) available for lysophosphatidic acid and Epithelial Ovarian Cancer
| Article | Year |
|---|---|
Preclinical detection of lysophosphatidic acid: A new window for ovarian cancer diagnostics.
Topics: Biomarkers, Tumor; Carcinoma, Ovarian Epithelial; Female; Humans; Lysophospholipids; Ovarian Neoplasms | 2022 |
Methods for quantifying lysophosphatidic acid in body fluids: a review.
Topics: Biomarkers, Tumor; Blood Chemical Analysis; Body Fluids; Carcinoma, Ovarian Epithelial; Colorimetry; Enzyme Assays; Enzyme-Linked Immunosorbent Assay; Fluorometry; Humans; Lysophospholipids; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms | 2014 |
12 other study(ies) available for lysophosphatidic acid and Epithelial Ovarian Cancer
| Article | Year |
|---|---|
Belly Fat Weakens Immune Fitness.
Topics: Abdominal Fat; Carcinoma, Ovarian Epithelial; Female; Humans; Interferon Type I; Lysophospholipids; Ovarian Neoplasms | 2022 |
Lysophosphatidic acid modulates ovarian cancer multicellular aggregate assembly and metastatic dissemination.
Topics: Animals; Carcinoma, Ovarian Epithelial; Cell Adhesion; Cell Aggregation; Cell Line, Tumor; Epithelial Cells; Female; Humans; Lysophospholipids; Mice; Mice, Inbred C57BL; Microscopy, Electron, Scanning; Microvilli; Ovarian Neoplasms; Peritoneal Neoplasms; Tumor Microenvironment | 2020 |
Chemical Analysis of Morphological Changes in Lysophosphatidic Acid-Treated Ovarian Cancer Cells.
Topics: Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Female; Humans; Lysophospholipids; Ovarian Neoplasms | 2017 |
TAZ mediates lysophosphatidic acid-induced migration and proliferation of epithelial ovarian cancer cells.
Topics: Butadienes; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cells, Cultured; Enzyme Inhibitors; Female; Gene Expression Regulation, Neoplastic; Humans; Intracellular Signaling Peptides and Proteins; Isoxazoles; Lysophospholipids; Neoplasms, Glandular and Epithelial; Nitriles; Ovarian Neoplasms; Propionates; Protein Stability; Trans-Activators; Transcription Factors; Transcriptional Coactivator with PDZ-Binding Motif Proteins | 2013 |
Lysophosphatidic Acid Initiates Epithelial to Mesenchymal Transition and Induces β-Catenin-mediated Transcription in Epithelial Ovarian Carcinoma.
Topics: Active Transport, Cell Nucleus; beta Catenin; Blotting, Western; Cadherins; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation, Neoplastic; Humans; Integrin beta1; Lysophospholipids; Microscopy, Fluorescence; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Protein Binding; Proto-Oncogene Proteins; Receptors, Lysophosphatidic Acid; Reverse Transcriptase Polymerase Chain Reaction; TCF Transcription Factors; Vimentin; Wnt Proteins; Wnt-5a Protein | 2015 |
FOXM1 is a downstream target of LPA and YAP oncogenic signaling pathways in high grade serous ovarian cancer.
Topics: Adaptor Proteins, Signal Transducing; Animals; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cystadenocarcinoma, Serous; Disease Progression; Dose-Response Relationship, Drug; Female; Forkhead Box Protein M1; Forkhead Transcription Factors; Gene Expression Regulation, Neoplastic; Humans; Lysophospholipids; Mice; Mice, Inbred NOD; Mice, SCID; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Phosphoproteins; RNA Interference; Signal Transduction; Transcription Factors; Transcription, Genetic; YAP-Signaling Proteins | 2015 |
Lysophosphatidic Acid Stimulates Urokinase Receptor (uPAR/CD87) in Ovarian Epithelial Cancer Cells.
Topics: Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Female; Humans; Lysophospholipids; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Receptors, Urokinase Plasminogen Activator; Urokinase-Type Plasminogen Activator | 2015 |
Autotaxin Regulates Maintenance of Ovarian Cancer Stem Cells through Lysophosphatidic Acid-Mediated Autocrine Mechanism.
Topics: Ataxin-1; Autocrine Communication; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Proliferation; Culture Media, Conditioned; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Humans; Lysophospholipids; Neoplasms, Glandular and Epithelial; Neoplastic Stem Cells; Ovarian Neoplasms; Phosphoric Diester Hydrolases; Proto-Oncogene Proteins c-akt; Receptors, Lysophosphatidic Acid; Signal Transduction | 2016 |
Lysophosphatidic acid-induced expression of periostin in stromal cells: Prognoistic relevance of periostin expression in epithelial ovarian cancer.
Topics: Actins; Adult; Aged; Carcinoma, Ovarian Epithelial; Cell Adhesion; Cell Adhesion Molecules; Cell Line, Tumor; Female; Fibroblasts; Humans; Immunohistochemistry; Lysophospholipids; Middle Aged; Neoplasm Invasiveness; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Prognosis; Stromal Cells | 2011 |
MMP-1-PAR1 axis mediates LPA-induced epithelial ovarian cancer (EOC) invasion.
Topics: Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Female; Humans; Lysophospholipids; Matrix Metalloproteinase 1; Matrix Metalloproteinase Inhibitors; Neoplasm Invasiveness; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; RNA, Messenger; RNA, Small Interfering; Transfection | 2011 |
The NF-κB pathway mediates lysophosphatidic acid (LPA)-induced VEGF signaling and cell invasion in epithelial ovarian cancer (EOC).
Topics: Carcinoma, Ovarian Epithelial; Cell Line, Tumor; ErbB Receptors; Female; Gene Expression Regulation, Neoplastic; Humans; Lysophospholipids; Matrix Metalloproteinases; Neoplasm Invasiveness; Neoplasms, Glandular and Epithelial; NF-kappa B; Ovarian Neoplasms; Signal Transduction; Up-Regulation; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2011 |
Elevated and secreted phospholipase A₂ activities as new potential therapeutic targets in human epithelial ovarian cancer.
Topics: Animals; Arachidonic Acids; Ascites; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Female; Humans; Lysophospholipids; Mice; Neoplasm Transplantation; Neoplasms, Glandular and Epithelial; Organophosphonates; Ovarian Neoplasms; Phospholipases A2, Secretory; Phosphoric Diester Hydrolases; Transplantation, Heterologous | 2012 |